miRNAs as Potential Biomarkers for Viral Hepatitis B and C

miRNAs as Potential Biomarkers for Viral Hepatitis B and C

Around 257 million people are living with hepatitis B virus (HBV) chronic infection and 71 million with hepatitis C virus (HCV) chronic infection. Both HBV and HCV infections can lead to liver complications such as cirrhosis and hepatocellular carcinoma (HCC). To take care of these chronically infec...

Full description

Bibliographic Details
Main Authors:	Dimitri Loureiro, Issam Tout, Stéphanie Narguet, Sabrina Menasria Benazzouz, Abdellah Mansouri, Tarik Asselah
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Viruses
Subjects:	liver inflammation chronic liver diseases chronic hepatitis fibrosis markers pro-fibrogenic
Online Access:	https://www.mdpi.com/1999-4915/12/12/1440

Similar Items

ANTI-FIBROTIC AND ANTIOXIDANT AMELIORATIVE EFFECTS OF NARINGENIN AGAINST THIOACETAMIDE INDUCED LIVER FIBROSIS
by: Haytham A. Ali, et al.
Published: (2023-01-01)

Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis
by: Eman El-Ahwany, et al.
Published: (2016-01-01)

Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics
by: David R. Brigstock
Published: (2021-06-01)

RELATIONSHIP OF THE MARKERS OF ENDOTHELIAL DYSFUNCTION AND FIBROSIS IN CHRONIC HEPATITIS AND CIRRHOSIS
by: V. V. Shchekotov, et al.
Published: (2014-07-01)

RELATIONSHIP OF THE MARKERS OF ENDOTHELIAL DYSFUNCTION AND FIBROSIS IN CHRONIC HEPATITIS AND CIRRHOSIS
by: V. V. Shchekotov, et al.
Published: (2014-07-01)

The Performance of Serum Biomarkers for Predicting Fibrosis in Patients with Chronic Viral Hepatitis
by: Chang Seok Bang, et al.
Published: (2017-05-01)

Non-invasive methods for the assessment of hepatic fibrosis: transient elastography, hyaluronic acid, 13C-aminopyrine breath test and cytokeratin 18 fragment
by: Gian Paolo Caviglia, et al.
Published: (2014-01-01)

Diagnostic Value of Conventional and Doppler Ultrasound Findings in Liver Fibrosis in Patients with Chronic Viral Hepatitis
by: Yasmin Davoudi, et al.
Published: (2015-09-01)

A novel non-invasive score for the prediction of advanced fibrosis in patients with chronic hepatitis B
by: Sannur Okdemir, et al.
Published: (2022-01-01)

Effects of vitamin D supplementation on liver fibrogenic factors, vitamin D receptor and liver fibrogenic microRNAs in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: an exploratory randomized clinical trial
by: Soraiya Ebrahimpour-Koujan, et al.
Published: (2024-02-01)

The Mechanism of miRNAs in Liver Fibrosis
by: HUANG Lu, et al.
Published: (2023-11-01)

Markers of progression of liver fibrotic changes in patients with chronic toxic drug-induced hepatitis
by: V.I. Didenko, et al.
Published: (2021-06-01)

Diagnostic Value of Serum Markers of Liver Fibrosis in Patients with HCV-Infection
by: S.L. Melanich
Published: (2013-11-01)

Elastography for Hepatic Fibrosis Severity in Chronic Hepatitis B or C
by: Maria-Vasiliki Papageorgiou, et al.
Published: (2011-01-01)

Ectopic Liver Tissue Formation in Rats with Induced Liver Fibrosis
by: Bauyrzhan Umbayev, et al.
Published: (2014-12-01)

The diagnostic value of a globulin/platelet model for evaluating liver fibrosis in chronic hepatitis B patients
by: Banu Demet Coskun, et al.
Published: (2015-12-01)

Quantitative Assessment of Liver Impairment in Chronic Viral Hepatitis with [<sup>99m</sup>Tc]Tc-Mebrofenin: A Noninvasive Attempt to Stage Viral Hepatitis-Associated Liver Fibrosis
by: Donatas Jocius, et al.
Published: (2022-09-01)

Evaluation of Non-invasive Diagnostic Methods as Indicators of Fibrosis in Patients with Chronic Hepatitis B
by: Kadri ATAY
Published: (2019-12-01)

Phenotype and function of MAIT cells in patients with alveolar echinococcosis
by: Jintian Li, et al.
Published: (2024-03-01)

Relationships between HBeAg status of patients with chronic hepatitis B and changes in serum TNF-α, viral load and severity of morphological changes in the liver according to non-invasive tests
by: A. B. Khelemendyk, et al.
Published: (2021-05-01)

Assessment of non-invasive models for liver fibrosis in chronic hepatitis B virus related liver disease patients in resource limited settings
by: Rakesh Shrivastava, et al.
Published: (2013-01-01)

Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study
by: Yoonseok Lee, et al.
Published: (2023-01-01)

Liver Fibrosis and 8-Year All-Cause Mortality Trajectories in the Aging Cohort of the Salus in Apulia Study
by: Roberta Zupo, et al.
Published: (2021-11-01)

The Predictive Value of Mean Platelet Volume for Liver Fibrosis in Children With Chronic Liver Diseases
by: Seyed Mohsen Dehghani, et al.
Published: (2020-12-01)

Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience
by: Joy Varghese, et al.
Published: (2017-03-01)

Diagnostic Accuracy of Serum Hepatitis B Virus DNA Levels and ALT for Liver Fibrosis
by: Madeeha Nazar
Published: (2018-01-01)

Matrix metalloproteinase-1 as a non-invasive biomarker to assess liver fibrosis in children with chronic liver disease
by: Ola Galal Behairy, et al.
Published: (2021-09-01)

Diagnostic value of serum markers of fibrosis in chronic liver diseases
by: E V Vinnitskaia, et al.
Published: (2013-02-01)

Ultrasonographic characteristics of morphometric and hemodynamic parameters of the liver and spleen in pediatric patients with chronic viral hepatitis B and C
by: Y. Demchyshyn, et al.
Published: (2021-11-01)

The value of osteopontin in predicting fibrosis in patients with chronic viral hepatitis C
by: A.G. Sheiko, et al.
Published: (2023-10-01)

Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms
by: Aragno Manuela, et al.
Published: (2012-10-01)

Diagnostic Accuracy of Indocyanine Green Clearance Test for Different Stages of Liver Fibrosis and Cirrhosis
by: Lukas Luerken, et al.
Published: (2023-08-01)

Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles
by: Hong Kiat Lim, et al.
Published: (2020-11-01)

Ultrasound-Based Liver Stiffness Surveillance in Patients Treated for Chronic Hepatitis B or C
by: Sheng-Hung Chen, et al.
Published: (2018-04-01)

Platelet Volume Indices as Non - Invasive Physiological Marker of Liver Fibrosis in Chronic Hepatitis C Patients
by: Yar Mohammad Nizamani, et al.
Published: (2017-06-01)

A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTION
by: A. A. Ostanin, et al.
Published: (2014-07-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

Role of macrophage-to-myofibroblast transition in chronic liver injury and liver fibrosis
by: Suhong Xia, et al.
Published: (2023-11-01)

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
by: Isabel Graupera, et al.
Published: (2022-07-01)

Place of Needle Biopsy in the Diagnosis of Chronic Diffuse Liver Diseases
by: D.V. Orlovsky, et al.
Published: (2013-04-01)